BICX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 19:22):

Stats
Dagens volum	405.00
Gjennomsnittsvolum	1 048.00
Markedsverdi	6.61M
EPS	$0 ( 2024-04-01 )
Neste inntjeningsdato	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Lucido Louis C.	Buy	21 552	Common Stock, par value $0.001
2024-03-28	Galligan Joseph J	Buy	5 566	Common Stock, par value $0.001
2024-01-02	Galligan Joseph J	Buy	6 173	Common Stock, par value $0.001
2024-03-28	Granier Brady James	Buy	16 698	Stock Option
2024-03-28	Murthy Harsha	Buy	5 566	Common Stock, par value $0.001

INSIDER POWER
100.00
Last 98 transactions
Buy: 908 641 \| Sell: 0

BioCorRx Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

BioCorRx Inc. Økonomi

Annual	2023
Omsetning:	$89 160.00
Bruttogevinst:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2023
Omsetning:	$89 160.00
Bruttogevinst:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2022
Omsetning:	$213 841
Bruttogevinst:	$198 562 (92.85 %)
EPS:	$-0.610

FY	2021
Omsetning:	$48 272.00
Bruttogevinst:	$42 391.00 (87.82 %)
EPS:	$-0.810

Financial Reports:

No articles found.

BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.